Systematic review of the safety of topical corticosteroids in pregnancy

Journal of the American Academy of Dermatology

Volumn 62, Issue 4, 2010, Pages 694-705

  Chi, Ching Chi ^a,b,c   Wang, Shu Hui ^b,c   Kirtschig, Gudula ^c,d   Wojnarowska, Fenella ^b,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c Department of Dermatology   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cochrane review; Newcastle Ottawa scale; pregnancy; systematic review; topical corticosteroid

Indexed keywords

CORTICOSTEROID DERIVATIVE;

APGAR SCORE; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; CONGENITAL DISORDER; DATA BASE; DRUG INDUSTRY; DRUG SAFETY; EDITORIAL; ENVIRONMENTAL EXPOSURE; FETUS DEATH; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY CONTROL; RATING SCALE; SIDE EFFECT; STILLBIRTH; SYSTEMATIC REVIEW;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; CLINICAL TRIALS AS TOPIC; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SAFETY; SKIN DISEASES;

EID: 77949273950     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.09.041     Document Type: Editorial

References (25)

1. Baumann L., and Kerdel F. Topical glucocorticoids. In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.I., et al. (Eds). Fitzpatrick's dermatology in general medicine (1999), McGraw-Hill, New York 2713-2717
2. Ambros-Rudolph C.M. Dermatoses of pregnancy. J Dtsch Dermatol Ges 4 (2006) 748-759
3. Cutivate cream [package insert] (2002), GlaxoSmithKline, Pittsburgh
4. Schering. ELOCON cream [package insert] (2003), Schering, Kenilworth
5. Yamada H., Nakano M., and Ichihashi T. Fetal concentration after topical application of betamethasone 17,21-dipropionate (S-3440) ointment and teratogenesis in mice and rabbits. [in Japanese]. Pharmacometrics 21 (1981) 645-655
6. Taro Pharmaceuticals. Diflorasone diacetate cream [package insert] (1999), Taro Pharmaceuticals, Hawthorne
7. Narama I. Reproduction studies of diflorasone diacetate (DDA), IV: teratogenicity study in rabbits by percutaneous administration. [in Japanese]. Pharmacometrics 28 (1984) 241-250
8. Chi C.C., Lee C.W., Wojnarowska F., and Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev (2009) 3:CD007346
9. Chi C.C., Lee C.W., Wojnarowska F., and Kirtschig G. Perinatal safety of topical corticosteroids for pregnant women. Cochrane Database Syst Rev (2008) 3:CD007346
10. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed November 23, 2006.
11. Czeizel A.E. Birth defects are preventable. Int J Med Sci 2 (2005) 91-92
12. Casey B.M., McIntire D.D., and Leveno K.J. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 344 (2001) 467-471
13. Czeizel A.E., and Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 56 (1997) 335-340
14. Mygind H., Thulstrup A.M., Pedersen L., and Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 81 (2002) 234-239
15. Edwards M.J., Agho K., Attia J., Diaz P., Hayes T., Illingworth A., et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A 120 (2003) 459-463
16. Källén B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 40 (2003) 624-628
17. Pradat P., Robert-Gnansia E., Di Tanna G.L., Rosano A., Lisi A., Mastroiacovo P., et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res 67 (2003) 968-970
18. Mahé A., Perret J.L., Ly F., Fall F., Rault J.P., and Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg 101 (2007) 183-187
19. Carmichael S.L., Shaw G.M., Ma C., Werler M.M., Rasmussen S.A., and Lammer E.J. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 197 (2007) 585 e1-7
20. Wong F.K., and Hagg U. An update on the etiology of orofacial clefts. Hong Kong Med J 10 (2004) 331-336
21. Altman D.G. Practical statistics for medical research (1991), Chapman & Hall, London
22. Arosarena O.A. Cleft lip and palate. Otolaryngol Clin North Am 40 (2007) 27-60
23. Chi C.C., Wang S.H., Charles-Holmes R., Ambros-Rudolph C., Powell J., Jenkins R., et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 160 (2009) 1222-1228
24. Briggs G.G., Freeman R.K., and Yaffe S.J. Drugs in pregnancy and lactation (2008), Lippincott Williams & Wilkins, Philadelphia
25. Womersley J., and Stone D.H. Epidemiology of facial clefts. Arch Dis Child 62 (1987) 717-720